| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JPS.20745 |
| P698 | PubMed publication ID | 17094130 |
| P50 | author | Tongwen Xu | Q59343616 |
| Longping Wen | Q79342201 | ||
| P2093 | author name string | Na Man | |
| Xiaomin Wang | |||
| Yiyun Cheng | |||
| Rongqiang Fu | |||
| Xueyuan Wang | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 595-602 | |
| P577 | publication date | 2007-03-01 | |
| P1433 | published in | Journal of Pharmaceutical Sciences | Q3186933 |
| P1476 | title | Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers | |
| P478 | volume | 96 |
| Q47447718 | Activated Microglia Targeting Dendrimer-Minocycline Conjugate as Therapeutics for Neuroinflammation |
| Q33845298 | Advanced Analgesic Drug Delivery and Nanobiotechnology. |
| Q30406066 | Dendrimer-coupled sonophoresis-mediated transdermal drug-delivery system for diclofenac |
| Q57812374 | Dendrimeric Poly(Epsilon-Lysine) Delivery Systems for the Enhanced Permeability of Flurbiprofen across the Blood-Brain Barrier in Alzheimer's Disease |
| Q37472758 | Dendrimeric nanoarchitectures mediated transdermal and oral delivery of bioactives |
| Q92255519 | Dendrimers as Pharmaceutical Excipients: Synthesis, Properties, Toxicity and Biomedical Applications |
| Q26825175 | Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues |
| Q33820501 | Dendrimers: synthesis, applications, and properties |
| Q64117846 | Designing and Characterization of a Novel Delivery System for Improved Cellular Uptake by Brain Using Dendronised Apo-E-Derived Peptide |
| Q37823446 | Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations |
| Q90353526 | Effect of 2nd and 3rd generation PAMAM dendrimers on proliferation, differentiation, and pro-inflammatory cytokines in human keratinocytes and fibroblasts |
| Q42946030 | Effect of Poly(amidoamine) Dendrimers on Corneal Penetration of Puerarin |
| Q36084040 | Effect of size, surface charge, and hydrophobicity of poly(amidoamine) dendrimers on their skin penetration |
| Q35171371 | Evaluation of cationic polyamidoamine dendrimers' dermal toxicity in the rat skin model |
| Q48331228 | Getting Drugs Across Biological Barriers. |
| Q64948539 | Hydrogel of ketoconazole and PAMAM dendrimers: formulation and antifungal activity. |
| Q27005267 | Immunosuppressive and anti-inflammatory properties of engineered nanomaterials |
| Q39038555 | In vitro cytotoxicity of the ternary PAMAM G3-pyridoxal-biotin bioconjugate |
| Q42009342 | Nanoparticles: Emerging carriers for drug delivery |
| Q34114833 | Nanosized ethosomes bearing ketoprofen for improved transdermal delivery. |
| Q104070180 | Poly(dimethylsiloxane): A sustainable human skin alternative for transdermal drug delivery prediction |
| Q90862847 | Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles |
| Q41837874 | The Effect of Cationic Polyamidoamine Dendrimers on Physicochemical Characteristics of Hydrogels with Erythromycin. |
| Q24616011 | Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery |
| Q33896898 | Transport and biodistribution of dendrimers across human fetal membranes: implications for intravaginal administration of dendrimer-drug conjugates |
Search more.